|
|
| 7:30 |
Registration |
| 8:00 |
Welcome and Introductions |
| 8:15 |
Future of Medicine Keynote
Metronomic antiangiogenic chemotherapy: past, present, and near future
Robert S. Kerbel, Ph.D., University of Toronto
|
Session I: New Targets and Strategies
| 9:00 |
Targeting tubulogenesis via Rasip1
Ondine Cleaver, Ph.D., University of Texas Southwestern Medical Center |
| 9:30 |
DEspR: Common target on tumor cells and tumor blood vessels
Victoria Herrera, M.D., Boston University School of Medicine |
| 10:00 |
GPCR Regulation of central nervous system angiogenesis
Calvin J. Kuo, M.D., Ph.D., Stanford University |
| 10:30 |
Break |
| 10:45 |
Multimedia Presentation: Visualizing angiogenesis
Joe Lertola, Bryan Christie Design |
| 11:00 |
Angiogenic regulation of tumor dormancy
Nava Almog, Ph.D., Tufts University |
| 11:30 |
FKBOL & Peptide derivatives for angiogenesis inhibition
Tracy Robson, MlBiol, Ph.D., Queens University Belfast |
| 12:00 |
Gliomablastoma vasculature and stem cells
Viviane Tabar, M.D., Memorial Sloan Kettering Cancer Center |
| 12:30 |
Moderated Panel Discussion
|
| 1:00 |
Networking Luncheon |
Session II: Angiogenesis Biomarkers
| 2:15 |
Angiome profiling: application to clinical trials
Herbert Hurwitz, M.D., Duke University Medical Center |
| 2:45 |
Translational studies for angiogenesis biomarkers
Dan G. Duda, Ph.D., D.M.D., Harvard Medical School |
| 3:15 |
Biomarker approaches in the early development of XL184
Dana T. Aftab, Ph.D., Exelixis, Inc. |
| 3:45 |
Break |
| 4:00 |
Preclinical development of an endogenous angiogenesis inhibitor: TIMP-2
William G. Stetler-Stevenson, M.D., Ph.D., National Cancer Institute |
| 4:30 |
Features of lung angiogenesis for targeting tumor angiogenesis
Moritz A. Konerding, M.D., Johannes Gutenberg University |
| 5:00 |
Moderated Panel Discussion
|
| 5:30 |
Networking Reception
|
| 7:30 |
Registration |
| 8:00 |
Summary of Day 1 and Opening Remarks |
Session III: Trends in Angioprevention
| 8:15 |
Future of Medicine Keynote - Angioprevention
Antiangiogenesis in a preventive setting: past, present and future of angioprevention
Adriana Albini, Ph.D., IRCCS Multimedica, Italy |
| 9:00 |
Translational evidence for the mechanism of catechins in angioprevention
Chung S. Yang, Ph.D., Rutgers University |
| 9:30 |
Dietary phytochemicals, skin cancer, angiogenic signaling pathways
Zigang Dong, M.D., Dr.P.H., The Hormel Institute, University of Minnesota |
| 10:00 |
Moderated Panel Discussion |
| 10:15 |
Break |
| 10:30 |
Patient Perspective Lecture |
Session IV: Clinical Development
| 10:45 |
Antiangiogenic therapy for prostate cancer
Walter M. Stadler, M.D., University of Chicago |
| 11:15 |
Translational priorities for antiangiogenic therapy development
Frank Cuttitta, Ph.D., National Cancer Institute |
| 11:45 |
What makes advanced cancers resistant to anti-VEGF therapy
Harold Dvorak, M.D., Beth Israel Deaconess Medical Center |
| 12:15 |
Moderated Panel Discussion
|
| 12:45 |
Luncheon |
| 2:00 |
Patient Perspective Lecture |
| 2:15 |
Antiangiogenic therapy for gastric cancers
Manish Shah, M.D., Weill Cornell Medical College |
| 2:45 |
Afilbercept: A new antiangiogenic agent with effectiveness in metastatic colorectal cancer
Edith Mitchell, M.D., Thomas Jefferson University |
| 3:15 |
Moving the bar forward in renal cell carcinoma
Sandy Srinivas, M.D., Stanford University |
| 3:45 |
Break |
| 4:00 |
Targeting vascular endothelial growth factor receptor in thyroid cancer
Steven I. Sherman, M.D., MD Anderson Cancer Center |
| 4:30 |
Bevacizumab in breast cancer: key lessons for clinical trials and patient-centered care
Hope S. Rugo, M.D., University California, San Francisco |
| 5:00 |
Moderated Panel Discussion
|
| 5:30 |
Closing Remarks & Close of Conference |
|
| |
|
| |
REGISTRATION
You will receive an email confirmation
of your registration after payment.
Select from the categories below to register for the conference.
Industry $698
|
Clinical/Academic $348
|
Student $198
|
Patient
|
The registration fee includes
- Access to both days of the conference
- Access to exhibit booth area
- Conference materials
- Breakfast on both days
- Lunch on both days
- Cocktail reception/networking event on Saturday evening, October 29th
|
|
Program Description